Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells

Journal of Human Virology

Volumn 1, Issue 2, 1998, Pages 69-76

  Shirazi, Yasaman ^a,b   Pitha, Paula M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

CXCR4 gene transcription; Interferons; Peripheral blood mononuclear cells

Indexed keywords

ALPHA INTERFERON; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; GAMMA INTERFERON; MESSENGER RNA; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL CULTURE; CELL FUSION; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MONONUCLEAR CELL; NORTHERN BLOTTING; PHYSIOLOGY; PLASMID;

BLOTTING, NORTHERN; CELL FUSION; CYTOKINES; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, ENV; GENE PRODUCTS, TAT; HIV-1; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; PLASMIDS; RECEPTORS, CXCR4; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031598711     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Weiss RA. Cellular receptors and viral glycoproteins involved in retrovirus entry. In: Levy J, ed. The retroviridae, vol 2. New York: Plenum Press, 1993:1-108.
2. Alkhatib G, Combadiere C, Broder CC, et al. CC-CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
3. Berson JF, Long D, Doranz BJ, Rucker J, Jirik FR, Doms RW. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J Virol 1996;70:6288-6295.
4. Choe H, Farzan M, Sun Y, et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
5. Deng HK, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-666.
6. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-673.
7. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactors: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
8. Doranz BJ, Ruker J, Yi Y, Smyth RJ, Samson M, Peiper SC, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-1158.
9. Rucker J, Samson M, Doranz BJ, Libert F, Berson JF, Yi Y, et al. Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 1996;87: 437-446.
10. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by deletion allele of the CKR5 structural gene. Science 1996;273:856-1862.
11. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, et al. Homozygous defect in HIV-1 coreceptors accounts for resistance of some multiply exposed individuals to HIV-1 infection. Cell 1996;86:367-377.
12. Samson M, Libert F, Doranz BJ, Ruker J, Liesnard C, Farbers CM, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-725.
13. Poli G, Fauci AS. Role of cytokines in the pathogenesis of human immunodeficiency virus infection. In: Aggarwal BB, Puri RK, eds. Human cytokines: their role in disease and therapy. Cambridge: Blackwell Science, 1995:421-449.
14. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 997;277:959-965.
15. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997;94:925-1930.
16. Loetscher P, Seitz M, Baggiolini M, Moser B. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 1996; 184:569-577.
17. Tangirala RK, Murao K, Quehenberger O. Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines. J Biol Chem 1997; 272:8050-8056.
18. Pitha PM. Multiple effects of interferon on HIV-1 replication. J Interferon Cytokine Res 1991;11:313-318.
19. Shirazi Y, Pitha PM. Alpha-interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J Virol 1992;66:1321-1328.
20. Shirazi Y, Pitha PM. Interferon α-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology 1993;193:303-312.
21. Sanes JR, Rubenstein JLR, Nicolas JF. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J 1986;5:3133-3142.
22. Nomura H, Nielsen BW, Matsushima K. Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors. Int Immunol 1993;5:1239-1249.
23. Loetscher M, Geiser T, O'Reilly T, Zwahlen R, Baggiolini M, Moser B. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leu-kocytes. J Biol Chem 1994;269:232-237.
24. Lapham CK, Ouyang J, Chandrasekhar B, Nguyen NY, Dimitrov DS, Golding H. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 1996;274:602-605.
25. Federsppiel B, Melhado IG, Duncan AM, et al. Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen. Genomics 1993;16:707-712.
26. Hammer SM, Gillis JM, Groopman JE, Rose, RM. In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and gamma interferon. Proc Natl Acad Sci USA 1986;83: 8734-8738.
27. Tsunetsugu-Yokota Y, Honda M. Effect of cytokines on HIV release and IL-2 alpha receptor expression in monocytic cell lines. J Acquir Immune Defic Syndr 1990;3:511-516.
28. Golding H, Dimitrov DS, Manischewitz J, Broder CC, Robinson J, Fabian S, et al. Phorbol ester-induced downmodulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules. J Virol 1995;69;6140-6148.
29. Kipmton J, Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J Virol 1992;66:2232-2239.
30. + T cells. Science 1995;270:1811-1815.
31. Conner RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997; 185:621-628.
32. + T cells. Science 1997;276:273-276.
33. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-534.
34. Unutmaz D, Littman DR. Expression pattern of HIV-1 coreceptors on T cells: implications for viral transmission and lymphocyte homing. Proc Natl Acad Sci USA 1997; 94:1615-1618.
35. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-1421.
36. Bhattacharya S, Eckner R, Grossman S, et al. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α. Nature 1996;383:344-347.
37. Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Darnell JEJ. Two contact regions between Stat1 and CBP/p300 in interferon-gamma signaling. Proc Natl Acad Sci USA 1996;93:15092-15096.
38. Horvai AE, Xu L, Korzus E, et al. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CDP and p300. Proc Natl Acad Sci USA 997;94:1074-1079.
39. Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 1997; 275:523-527.
40. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 1997;94: 2927-2932.
41. Xu J, Rockow S, Kim S, Xiong W, Li W. Interferons block protein kinase C-dependent but not independent activation of Raf-1 and mitogen-activated protein kinases and mitogenesis in NIH 3T3 cells. Mol Cell Biol 1994;14:8018-8027.
42. Schutze S, Berkovic D, Tomsing O, Unger C, Kronke M. Tumor necrosis factor induces rapid production of 1′2′-diacylglycerol by a phosphatidylcholine-specific phospholipase C. J Exp Med 1991;174:975-988.
43. Kolch W, Heidecker G, Kochs G, et al. PKCα activates Raf-1 by direct phosphorylation. Nature 1993;364:249-251.
44. Rogge L, Barberis-Maino L, Biffi M, et al. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997;185:825-831.
45. h2 cells. J Exp Med 1997;185: 817-824.
46. H2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
47. Agosti JM, Coombs RW, Collier AC, et al. A randomized, double-blind, phase I/II trial of tumor necrosis factor and interferon gamma for treatment of AIDS-related complex. AIDS Res Hum Retroviruses 1992;8:581-7.
48. Kunzi MS, Farzadegan H, Margolick JB, Vlahov D, Pitha PM. Identification of human immunodeficiency virus primary isolates resistant to interferon-α and correlation of prevalence to disease progression. J Infect Dis 1995;171: 822-828.
49. Zagury D. C-C chemokines, IFN-α and tat, pivotal in HIV-1 prevention and evolution towards AIDS. Presented at the second annual meeting of the Institute of Human Virology, Baltimore, MD, September 15-21, 1997.